CorMedix dismisses CBIZ CPAs, appoints EY as auditor; cites material weakness in internal controls

CorMedix Inc.

Audit Committee dismissed CBIZ CPAs on June 25, 2026, and appointed Ernst & Young as new independent auditor for FY 2026.
CBIZ CPAs' report on FY 2025 financials was unqualified; no disagreements on accounting principles.
A material weakness in internal control over financial reporting was identified (operational effectiveness of review of non-routine transactions).
The material weakness was previously reported in the 2025 10-K filed March 5, 2026.
CBIZ CPAs provided a letter dated July 1, 2026, agreeing with the statements in this 8-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.